Crystalvue Medical Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Crystalvue Medical.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 21.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 06 Oct 2023 |
Recent future growth updates
No updates
Recent updates
The Returns On Capital At Crystalvue Medical (GTSM:6527) Don't Inspire Confidence
Apr 05Has Crystalvue Medical Corporation (GTSM:6527) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Mar 10Consider This Before Buying Crystalvue Medical Corporation (GTSM:6527) For The 5.2% Dividend
Feb 10Are Crystalvue Medical's (GTSM:6527) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 20The Returns At Crystalvue Medical (GTSM:6527) Provide Us With Signs Of What's To Come
Dec 30Could The Market Be Wrong About Crystalvue Medical Corporation (GTSM:6527) Given Its Attractive Financial Prospects?
Dec 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 961 | 138 | 64 | 114 | 1 |
12/31/2023 | 824 | 103 | 145 | 154 | N/A |
9/30/2023 | 866 | 115 | 92 | 97 | N/A |
6/30/2023 | 856 | 128 | 76 | 80 | N/A |
3/31/2023 | 866 | 120 | 57 | 64 | N/A |
12/31/2022 | 795 | 115 | 43 | 52 | N/A |
9/30/2022 | 757 | 108 | 168 | 116 | N/A |
6/30/2022 | 728 | 89 | 168 | 115 | N/A |
3/31/2022 | 682 | 80 | -196 | 90 | N/A |
12/31/2021 | 722 | 77 | -220 | 63 | N/A |
9/30/2021 | 701 | 70 | -291 | 70 | N/A |
6/30/2021 | 675 | 75 | -398 | 39 | N/A |
3/31/2021 | 568 | 64 | -75 | 26 | N/A |
12/31/2020 | 504 | 57 | -20 | 84 | N/A |
9/30/2020 | 489 | 62 | 5 | 94 | N/A |
6/30/2020 | 505 | 61 | 66 | 78 | N/A |
3/31/2020 | 597 | 73 | 100 | 108 | N/A |
12/31/2019 | 661 | 91 | 92 | 98 | N/A |
9/30/2019 | 687 | 94 | 77 | 93 | N/A |
6/30/2019 | 685 | 98 | 92 | 108 | N/A |
3/31/2019 | 657 | 89 | 78 | 99 | N/A |
12/31/2018 | 606 | 70 | 75 | 101 | N/A |
9/30/2018 | 548 | 55 | 21 | 37 | N/A |
6/30/2018 | 507 | 41 | 35 | 52 | N/A |
3/31/2018 | 500 | 37 | 39 | 51 | N/A |
12/31/2017 | 494 | 34 | 42 | 50 | N/A |
9/30/2017 | 487 | 33 | N/A | 54 | N/A |
6/30/2017 | 481 | 32 | N/A | 58 | N/A |
3/31/2017 | 512 | 41 | N/A | 62 | N/A |
12/31/2016 | 542 | 50 | N/A | 67 | N/A |
9/30/2016 | 552 | 58 | N/A | 59 | N/A |
6/30/2016 | 562 | 67 | N/A | 50 | N/A |
3/31/2016 | 513 | 59 | N/A | 35 | N/A |
12/31/2015 | 465 | 51 | N/A | 19 | N/A |
9/30/2015 | 444 | 48 | N/A | 24 | N/A |
6/30/2015 | 423 | 45 | N/A | 30 | N/A |
3/31/2015 | 411 | 44 | N/A | 43 | N/A |
12/31/2014 | 398 | 42 | N/A | 57 | N/A |
12/31/2013 | 404 | 34 | N/A | 11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6527's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 6527's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 6527's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 6527's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 6527's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6527's Return on Equity is forecast to be high in 3 years time